Reducing time-to-treatment in oncology care delivery is a health-system operations problem in which the interval from diagnosis (biopsy) to first therapeutic intervention is treated as a measurable, improvable quality metric, subject to both cross-cutting organizational barriers and disease-specific bottlenecks (such as multi-specialty surgical coordination or diagnostic entry-point fragmentation). The underlying principle draws on continuous-improvement/process-mapping methodology (identifying all system entry points and workflow steps, then re-engineering scheduling and resource allocation, such as team-based rather than individual-surgeon slot assignment) to shorten cycle time, on the premise that access delay affects both patient psychological burden and clinical outcomes. This belongs to healthcare operations management and quality improvement within oncology care delivery, relating to broader principles of process/value-stream analysis, organizational change management, and patient-centered access metrics.
Reducing time-to-treatment in oncology care delivery is a health-system operations problem in which the interval from diagnosis (biopsy) to first therapeutic intervention is treated as a measurable, …